ArticleJournal for immunotherapy of cancer2022

Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.

Pan Juncheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.